Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Evaris Pharma is a specialty pharmaceutical company headquartered in East Windsor, New Jersey, specializing in the development, manufacturing, and commercialization of complex generic prescription drugs. The company operates a 65,000-square-foot, state-of-the-art facility that integrates R&D with high-capacity manufacturing to produce oral solids and other dosage forms. Evaris focuses on high-barrier-to-entry products, aiming to provide cost-effective and high-quality alternatives to brand-name pharmaceuticals. Their portfolio includes a range of generic medicines designed to improve patient access and affordability within the healthcare system. By leveraging its internal technical expertise and robust supply chain, Evaris Pharma maintains a commitment to quality and regulatory compliance in the competitive generics market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Evaris Pharma.